{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:45:50Z","timestamp":1793925950760,"version":"4.8.0"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,12,5]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the effects of coenzyme Q10 (CoQ10) for reduction in the severity, frequency of migraine attacks and duration of headache in adult patients with migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Cochrane Central Register of Controlled Trials, CENTRAL, MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Psychological Information Database (PsycINFO) from inception till December 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study selection<\/jats:title>\n                    <jats:p>All randomised control trials comparing CoQ10 with placebo or used as an adjunct treatment included in this meta-analysis. Cross-over designs and controlled clinical trials were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data synthesis<\/jats:title>\n                    <jats:p>\n                      Heterogeneity at face value by comparing populations, settings, interventions and outcomes were measured and statistical heterogeneity was assessed by means of the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic. The treatment effect for dichotomous outcomes were using risk ratios and risk difference, and for continuous outcomes, mean differences (MDs) or standardised mean difference; both with 95% CIs were used. Subgroup analyses were carried out for dosage of CoQ10 and if CoQ10 combined with another supplementation. Sensitivity analysis was used to investigate the impact risk of bias for sequence generation and allocation concealment of included studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six studies with a total of 371 participants were included in the meta-analysis. There is no statistically significant reduction in severity of migraine headache with CoQ10 supplementation. CoQ10 supplementation reduced the duration of headache attacks compared with the control group (MD: \u22120.19; 95%\u2009CI: \u22120.27 to \u22120.11; random effects; I\n                      <jats:sup>2<\/jats:sup>\n                      statistic=0%; p&lt;0.00001). CoQ10 usage reduced the frequency of migraine headache compared with the control group (MD: \u22121.52; 95%\u2009CI: \u22122.40 to \u22120.65; random effects; I\n                      <jats:sup>2<\/jats:sup>\n                      statistic=0%; p&lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CoQ10 appears to have beneficial effects in reducing duration and frequency of migraine attack.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42019126127.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-039358","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T14:48:03Z","timestamp":1609858083000},"page":"e039358","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":51,"title":["Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine\u2014a meta-analysis"],"prefix":"10.1136","volume":"11","author":[{"given":"Suhairul","family":"Sazali","sequence":"first","affiliation":[{"name":"Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7353-2839","authenticated-orcid":false,"given":"Salziyan","family":"Badrin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-1476","authenticated-orcid":false,"given":"Mohd Noor","family":"Norhayati","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Suhaila","family":"Idris","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"2025121603355875000_11.1.e039358.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007646.x"},{"key":"2025121603355875000_11.1.e039358.2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0846-2"},{"key":"2025121603355875000_11.1.e039358.3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1526-4610.2007.00652.x","article-title":"Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine","volume":"47","author":"Hershey","year":"2007","journal-title":"Headache"},{"key":"2025121603355875000_11.1.e039358.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01954.x"},{"key":"2025121603355875000_11.1.e039358.5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421227"},{"key":"2025121603355875000_11.1.e039358.6","doi-asserted-by":"publisher","DOI":"10.1179\/1476830513Y.0000000106"},{"key":"2025121603355875000_11.1.e039358.7","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414566817"},{"key":"2025121603355875000_11.1.e039358.8","doi-asserted-by":"publisher","DOI":"10.1080\/10715760600617843"},{"key":"2025121603355875000_11.1.e039358.9","doi-asserted-by":"crossref","unstructured":"Higgins JPT TJ , Chandler J , Cumpston M . Cochrane Handbook for systematic reviews of interventions version 6.0 (updated July 2019. London: Cochrane, 2019. www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"2025121603355875000_11.1.e039358.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39490.551019.BE"},{"key":"2025121603355875000_11.1.e039358.11","unstructured":"The Nordic Cochrane Centre TCC . Review manager (RevMan). version 5.3. Copenhagen: The Nordic Cochrane centre, The Cochrane collaboration, 2014."},{"key":"2025121603355875000_11.1.e039358.12","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1007\/s10072-010-0276-7","article-title":"Non-pharmacological management of migraine during pregnancy","volume":"31 Suppl 1","author":"Airola","year":"2010","journal-title":"Neurol Sci"},{"key":"2025121603355875000_11.1.e039358.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(04)69011-X"},{"key":"2025121603355875000_11.1.e039358.14","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-013-1403-z","article-title":"Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I","volume":"34","author":"Carotenuto","year":"2013","journal-title":"Neurol Sci"},{"key":"2025121603355875000_11.1.e039358.15","doi-asserted-by":"crossref","DOI":"10.1186\/1129-2377-16-S1-A186","article-title":"P026. pilot study on the use of coenzyme Q10 in a group of patients with episodic migraine without aura","volume":"16","author":"Dalla Volta","year":"2015","journal-title":"J Headache Pain"},{"key":"2025121603355875000_11.1.e039358.16","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-016-0398-1","article-title":"Nutraceuticals in acute and prophylactic treatment of migraine","volume":"18","author":"Daniel","year":"2016","journal-title":"Curr Treat Options Neurol"},{"key":"2025121603355875000_11.1.e039358.17","unstructured":"Di Lorenzo C . The use of a phytotherapic compound containing Tanacetum Parthenium and Andrographis, in combination with CoQ10 and riboflavin, for migraine prophylaxis: a randomized double blind versus placebo clinical trial. J Headache Pain 2018;19."},{"key":"2025121603355875000_11.1.e039358.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-010-0411-5"},{"key":"2025121603355875000_11.1.e039358.19","article-title":"A proprietary supplement containing riboflavin, magnesium and Q10 improves migraine symptoms in a randomized placebo-controlled double-blind trial","volume":"35","author":"Gaul","year":"2015","journal-title":"J Headache Pain"},{"key":"2025121603355875000_11.1.e039358.20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00335.x"},{"key":"2025121603355875000_11.1.e039358.21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eujim.2017.10.003","article-title":"Efficacy of coenzyme Q10 for the prevention of migraine in women: a randomized, double-blind, placebo-controlled study","volume":"16","author":"Dahri","year":"2017","journal-title":"Eur J Integr Med"},{"key":"2025121603355875000_11.1.e039358.22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/1028415X.2017.1421039","article-title":"Oral coenzyme Q10 supplementation in patients with migraine: effects on clinical features and inflammatory markers","volume":"22","author":"Dahri","year":"2019","journal-title":"Nutr Neurosci"},{"key":"2025121603355875000_11.1.e039358.23","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-015-0516-6","article-title":"Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial","volume":"16","author":"Gaul","year":"2015","journal-title":"J Headache Pain"},{"key":"2025121603355875000_11.1.e039358.24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/0333102418821661","article-title":"The effects of concurrent coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial","volume":"39","author":"Hajihashemi","year":"2019","journal-title":"Cephalalgia"},{"key":"2025121603355875000_11.1.e039358.25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eujim.2018.06.009","article-title":"The effect of coenzyme Q10 supplementation on serum levels of lactate, pyruvate, matrix metalloproteinase 9 and nitric oxide in women with migraine. A double blind, placebo, controlled randomized clinical trial","volume":"21","author":"Nattagh-Eshtivani","year":"2018","journal-title":"Eur J Integr Med"},{"key":"2025121603355875000_11.1.e039358.26","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000151975.03598.ED"},{"key":"2025121603355875000_11.1.e039358.27","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"2025121603355875000_11.1.e039358.28","doi-asserted-by":"crossref","first-page":"s18","DOI":"10.1007\/s101940300003","article-title":"Epidemiology of migraine","volume":"4","author":"Manzoni","year":"2003","journal-title":"J Headache Pain"},{"key":"2025121603355875000_11.1.e039358.29","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.19082\/6279","article-title":"Prophylactic effect of riboflavin on pediatric migraine: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Talebian","year":"2018","journal-title":"Electron Physician"},{"key":"2025121603355875000_11.1.e039358.30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/cjn.2018.394","article-title":"Vitamins and minerals for migraine prophylaxis: a systematic review and meta-analysis","volume":"46","author":"Okoli","year":"2019","journal-title":"Can J Neurol Sci"},{"key":"2025121603355875000_11.1.e039358.31","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/1028415X.2019.1572940","article-title":"Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials","volume":"23","author":"Parohan","year":"2020","journal-title":"Nutr Neurosci"},{"key":"2025121603355875000_11.1.e039358.32","first-page":"1904","article-title":"Coenzyme Q10 in migraine prophylaxis: a randomized, double-blind, placebo-controlled clinical trial","volume":"33","author":"Khorvash","year":"2016","journal-title":"Journal of Isfahan Medical School"},{"key":"2025121603355875000_11.1.e039358.33","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411406755"},{"key":"2025121603355875000_11.1.e039358.34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s13760-016-0697-z","article-title":"Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial","volume":"117","author":"Shoeibi","year":"2017","journal-title":"Acta Neurol Belg"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-039358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:36:06Z","timestamp":1765884966000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-039358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,5]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bmjopen-2020-039358"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-039358","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}